FDA Reversals, Pharma Momentum, and Why Patients Can’t Afford to Be Silent Originally posted on obesity.news on January 13th, 2026 GLP-1, Maritide, and Oprah, A Week That Felt Different at OTP A lot happened in the broader GLP-1 world this week, but what stood out to me wasn’t just the headlines. It was how Dave kept returning to the same core question on air: what does this actually mean for patients? Whether he was reacting to regulatory shifts, pharma claims, or mainstream voices...

New GLP-1 Data, Alzheimer’s Trials, and Rebuilding @OTPHQ on TikTok Original posted at obesity.news/  on Nov 24, 2025 This Week On The Pen: Gratitude, a TikTok Gut-Punch, and the Next Wave of GLP-1 Data This week’s On The Pen live podcast opened on an unexpectedly emotional note. During Thanksgiving week, a time Dave framed through the lens of that first, uncertain Thanksgiving; he described losing his TikTok account, a community of nearly 60,000 followers, in a single automated decision. No...

Original posted at obesity.news/  on Dec 09, 2025 Hey OTP friends, it’s Ann again. This episode is a bit of a milestone: it’s the first Tuesday “Weekly Dose” podcast we’ve done live since moving to a full live schedule on Mondays, Wednesdays, and Fridays , because Dave has officially gone full-time with On The Pen. That leap is only possible because of this community: your attention, your comments, your shares, and your trust. This rundown is my way of helping you see the through-line in a...